Healthcare
AmerisourceBergen Corporation(ABC)
Data coverage status · 6 need attention
Quote: Stale
Quote synced 2026-08-02T22:23:27.929802Z
Daily bars through 2023-09-25 · Stale
Daily bars synced 2026-07-03T20:19:37.490316Z
Fundamentals through 2026-05-04 · Delayed
Fundamentals synced 2026-05-15T20:32:07.021273Z
Forecasts: Stale
Forecasts synced 2026-05-05T11:56:10.905225Z
Ownership: Missing
Ownership synced 2026-05-15T20:32:07.021273Z
Short interest: Missing
Short interest synced 2026-05-15T20:32:07.021273Z
News through 2026-05-12T18:03:59Z · Stale
News synced 2026-05-12T22:16:20.907261Z
Company profile: Delayed
Company profile synced 2026-05-06T21:57:05.374448Z
Regular-session price
Offline—
1Y Change
—
Window
No data
- Market Cap
- $36.15B
- P/E
- 36.3
- Trailing
- 52W Range
- $136.07 - $194.79
- Volume
- 806.05K
- 0.6x RVOL
Investment Snapshot
Valuation, growth, profitability, catalysts, and benchmark context.
1D
—
1M
—
6M
—
YTD
—
1Y
—
- Market Cap
- $36.15B
- NYSE
- P/E
- 36.3
- Trailing valuation
- Revenue Growth
- +9.3%
- TTM growth
- EPS Growth
- +5.5%
- TTM earnings growth
- Operating Margin
- 1.2%
- TTM profitability
- Forward P/E
- —
- Waiting on consensus EPS
- Next Earnings
- Nov 4, 2026
- In 91 days
- 52W Position
- --
- $136.07 - $194.79
- Volume
- 0.6x
- 806.05K shares latest
- Benchmark
- --
- vs SPY over 1Y
- Dividend
- 0.8%
- Last ex-date Aug 10, 2023
Historical coverage is still loading
We are still backfilling 1Y daily history for this symbol. Some charts may stay empty until more data arrives.
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
AmerisourceBergen Corporation (ABC) is a Healthcare stock with listed on NYSE. Baseline metrics include revenue growth of +9.3%, EPS growth of +5.5%, a dividend yield of 0.8%. What stands out right now is revenue +9.3%, EPS +5.5%, free cash flow +7.0% with operating margin 1.2% and ROIC 13.8%. The dividend is present but secondary, with a yield around 0.8%. Valuation already assumes a fairly strong business story at P/E 36.3 and price/sales 0.2. Stock Foundry combines ABC price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Sector Context
How this name stacks up against nearby peers on first-pass metrics.
Revenue Growth
Above sector median
+9.3% vs +6.2% peer median
Operating Margin
Below sector median
+1.2% vs +19.7% peer median
P/E
Below sector median
36.3 vs 101.5 peer median
What Changed This Quarter
Latest report context and the signals most likely to have changed the story.
Latest report is on the board
2026 was reported on Feb 4, 2026, but the surprise data is still limited.
The operating story is still moving forward
Revenue is running at +9.3% and EPS at +5.5%, with operating margin around 1.2%.
The next real check-in already has a date
The next earnings event is scheduled for Nov 4, 2026, which is the clearest near-term catalyst for confirming whether the current trend is holding up.
Benchmark Edge
ABC vs SPY, QQQ, and Sector ETFs
Normalized return, excess return, max drawdown, and calendar-year wins against the benchmarks investors actually use.
ABC
—
Normalized return
SPY
--
S&P 500
Excess Return
--
Relative to SPY
ABC Max Drawdown
—
Trailing 1Y
SPY Max Drawdown
—
Trailing 1Y
Calendar-Year Returns
Uses the longest available daily history for ABC and SPY.
Company Overview
AmerisourceBergen Corporation
New York Stock Exchange
AmerisourceBergen Corporation sources and distributes pharmaceutical products in the United States and internationally. Its Pharmaceutical Distribution segment distributes brand-name and generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to various healthcare providers, including acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers. It also provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; and packaging solutions to various institutional and retail healthcare providers. In addition, this segment distributes plasma and other blood products, injectable pharmaceuticals, vaccines, and other specialty products; provides other services primarily to physicians who specialize in various disease states, primarily oncology, as well as to other healthcare providers, including hospitals and dialysis clinics; and offers data analytics, outcomes research, and additional services for biotechnology and pharmaceutical manufacturers. The company's Other segment provides integrated manufacturer services, such as clinical trial support, product post-approval, and commercialization support; specialty transportation and logistics services for the biopharmaceutical industry; and sells pharmaceuticals, vaccines, parasiticides, diagnostics, micro feed ingredients, and various other products to customers in the companion animal and production animal markets, as well as demand-creating sales force services to manufacturers. AmerisourceBergen Corporation was incorporated in 2001 and is headquartered in Conshohocken, Pennsylvania.
- Leadership
- Steven H. Collis
- IPO Date
- Apr 4, 1995
- Employees
- 46.0k
- Street Address
- 1 West First Avenue
- Mailing
- Conshohocken, PA, 19428-1800
- Region
- Conshohocken, PA, US
- Reporting Currency
- USD
- Investor Line
- 610 727 7000
- Last Updated
- May 6, 2026
Statistics & Key Fundamentals
Valuation, growth, profitability, and balance sheet signals.
Valuation
- P/E
- 36.3
- EV/EBITDA
- 17.1
- Price/Sales
- 0.2
- Price/Book
- 30.9
Growth
- Revenue
- +9.3%
- EPS
- +5.5%
- Free Cash Flow
- +7.0%
Profitability
- Gross Margin
- 3.3%
- Operating Margin
- 1.2%
- Net Margin
- 0.5%
- ROE
- 101.4%
- ROIC
- 13.8%
Balance Sheet
- Debt/Equity
- 4.15
- Current Ratio
- 0.92
Earnings Reports
Latest News
Next Step
Keep the research moving
After the overview, the strongest next step is usually chart context or a tighter compare set.